Admission and hospitalization
|
Gender
| | | | | | |
Male
|
25
|
12
| | | | |
Female
|
190
|
88
| | | | |
Ethnicity
| | | | | | |
Hispanic or Latino
|
5
|
2
| | | | |
Not Hispanic or Latino
|
210
|
98
| | | | |
Race
| | | | | | |
White
|
185
|
86
| | | | |
Black or African American
|
10
|
5
| | | | |
Asian
|
5
|
2
| | | | |
Other
|
15
|
7
| | | | |
Diagnosis (DSM-5)
| | | | | | |
Anorexia Nervosa (AN)
|
138
|
64
| | | | |
Bulimia Nervosa (BN)
|
12
|
6
| | | | |
Avoidant-Restrictive Food Intake Disorder (ARFID)
|
9
|
4
| | | | |
Atypical anorexia
|
38
|
18
| | | | |
Purging disorder
|
10
|
5
| | | | |
Unspecified Food and Eating Disorder (UFED)
|
8
|
3
| | | | |
Age, Years
|
215
| |
5.8
|
23.2
|
15.3
|
2.8
|
Duration illness, months
|
215
| |
0.7
|
115.4
|
18.8
|
21.4
|
Height, cm
|
215
| |
112.3
|
179.0
|
159.3
|
11.5
|
Weight, kg
|
215
| |
17.2
|
107.2
|
44.1
|
11.5
|
BMI, kg/m2
|
215
| |
11.2
|
35.4
|
17.1
|
3.1
|
BMI Z-Score
|
215
| |
−10.1
|
2.2
|
−1.6
|
1.5
|
Degree of malnutrition
| | | | | | |
Mild malnutrition
|
11
|
5
| | | | |
Moderate malnutrition
|
23
|
11
| | | | |
Severe malnutrition
|
181
|
84
| | | | |
Percentage Median BMI (%MBMI)
|
215
| |
52.5
|
153.7
|
86.1
|
13.9
|
Treatment goal weight (TGW: Projected growth curves)
|
215
| |
19.0
|
85.6
|
54.0
|
11.2
|
Percentage TGW
|
215
| |
47.9
|
131.2
|
81.2
|
9.6
|
Length of stay, days
|
215
| |
3
|
40
|
11
|
5
|
Length on telemetry/ICU, days
|
18
| |
1
|
9
|
3
|
3
|
Resting energy expenditure
|
215
| |
872
|
2235
|
1279
|
174
|
Admission calories
|
215
| |
900
|
2800
|
1466
|
399
|
Admission calories/REE
|
215
| |
0.54
|
2.39
|
1.16
|
0.34
|
Discharge calories
|
215
| |
1800
|
5600
|
3754
|
672
|
Discharge calories/REE
|
215
| |
1.07
|
4.37
|
2.96
|
0.50
|
Rate of calorie change, kcals/day
|
215
| |
25
|
520
|
223
|
75
|
Admission - discharge calorie change
|
215
| |
200
|
4400
|
2288
|
712
|
Admission- discharge calorie change/REE
|
215
| |
0.14
|
3.28
|
1.79
|
0.51
|
Required nasogastric feeds
|
22
|
10
| | | | |
On psychotropic meds during stay
|
75
|
35
| | | | |
Benzodiazepines
|
25
|
11.6
| | | | |
SSRI’s
|
26
|
12.1
| | | | |
Atypical antipsychotiics
|
20
|
9.3
| | | | |
SNRI
|
6
|
2.7
| | | | |
Mood stabilizers (anticonvulsants)
|
5
|
2.3
| | | | |
Alpha agonists
|
4
|
1.8
| | | | |
Tricyclic antidepressants
|
3
|
1.4
| | | | |
Stimulants
|
1
|
0.4
| | | | |
Other (Mirtazapine, Buspirone, Trazodone)
|
7
|
3.2
| | | | |
Supplementation required
| | | | | | |
Phosphorus
|
31
|
14
| | | | |
Potassium
|
9
|
4
| | | | |
Magnesium
|
6
|
3
| | | | |
Percentage transferred to a higher level of care
|
32
|
14.9
| | | | |
Discharge
|
Discharge BMI
|
215
| |
12.8
|
33.8
|
18.2
|
2.9
|
Discharge %MBMI
|
215
| |
60.1
|
146.8
|
91.4
|
13.6
|
Discharge %TGW
|
215
| |
58.1
|
125.3
|
86.1
|
8.9
|
Percentage MBMI Gain from Admission
|
215
| |
−7.1
|
21.9
|
5.3
|
3.7
|
Percentage TGW Gain from Admission
|
215
| |
−5.9
|
22.1
|
5.0
|
3.5
|
Weight Gain, kg, from Admission
|
215
| |
−4.8
|
6.7
|
2.5
|
1.7
|
Average daily weight gain, kg
|
215
| |
−0.96
|
0.57
|
0.22
|
0.16
|
Follow Up
|
Percentage rehospitalized
| | | | | | |
Within 30 days
|
6
|
3.8
| | | | |
Within 1 year
|
37
|
17.2
| | | | |
4 Weeks Follow-up BMI
|
157
| |
13.6
|
34.2
|
20.0
|
2.8
|
4 Weeks Follow-up %MBMI
|
157
| |
66.1
|
148.6
|
100.9
|
12.9
|
4 Weeks Follow-up %TGW
|
157
| |
65.4
|
126.0
|
94.9
|
9.4
|
Percentage MBMI Gain from Discharge
|
157
| |
−12.8
|
25.4
|
9.2
|
6.0
|
Percentage TGW Gain from Discharge
|
157
| |
−13.5
|
23.9
|
8.8
|
5.7
|
Weight Gain, kg, from Discharge
|
157
| |
−6.7
|
11.9
|
4.6
|
3.0
|